Search Results - "Caruso, Vincent M"

Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy by Rac, Goran, Patel, Hiten D., James, Christopher, Desai, Shalin, Caruso, Vincent M., Fischer, Daniel S., Lentz, Peter S., Ward, Ceressa T., Mazzarella, Brian C., Phillips, Kevin G., Doshi, Chirag, Bicocca, Vincent T., Levin, Trevor G., Wolfe, Alan J., Gupta, Gopal N.

“…Intravesical therapy (IVT) is the standard of care to decrease risk of recurrence and progression for high‐grade nonmuscle‐invasive bladder cancer. However,…”
Get full text

Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction by Salari, Keyan, Sundi, Debasish, Lee, Jason J, Wu, Shulin, Wu, Chin-Lee, DiFiore, Gabrielle, Yan, Q Robert, Pienkny, Andrew, Lee, Chi K, Oberlin, Daniel, Barme, Greg, Piser, Joel, Kahn, Robert, Collins, Edward, Phillips, Kevin G, Caruso, Vincent M, Goudarzi, Mahdi, Garcia-Ransom, Monica, Lentz, Peter S, Evans-Holm, Martha E, MacBride, Andrew R, Fischer, Daniel S, Haddadzadeh, Iden J, Mazzarella, Brian C, Gray, Joe W, Koppie, Theresa M, Bicocca, Vincent T, Levin, Trevor G, Lotan, Yair, Feldman, Adam S

“…Urinary comprehensive genomic profiling (uCGP) uses next-generation sequencing to identify mutations associated with urothelial carcinoma (UC) and has the…”
Get full text

Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer Treated with Nadofaragene Firadenovec by Narayan, Vikram M., Tholomier, Come, Mokkapati, Sharada, Martini, Alberto, Caruso, Vincent M., Goudarzi, Mahdi, Mazzarella, Brian C., Phillips, Kevin G., Bicocca, Vincent T., Levin, Trevor G., Yla-Herttuala, Seppo, McConkey, David J., Dinney, Colin P.N.

“…In patients with bacillus Calmette-Guérin–unresponsive non–muscle-invasive bladder cancer, urine DNA profiling identifies those with the greatest likelihood of…”
Get full text

Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of Intervention by Bicocca, Vincent T., Phillips, Kevin G., Fischer, Daniel S., Caruso, Vincent M., Goudarzi, Mahdi, Garcia-Ransom, Monica, Lentz, Peter S., MacBride, Andrew R., Jensen, Brad W., Mazzarella, Brian C., Koppie, Theresa, Korkola, James E., Gray, Joe W., Levin, Trevor G.

“…The clinical standard of care for urothelial carcinoma (UC) relies on invasive procedures with suboptimal performance. To enhance UC treatment, we developed a…”
Get full text

MP16-07 URINARY MINIMAL RESIDUAL DISEASE DETECTION PREDICTS RECURRENCE IN BCG-UNRESPONSIVE NIMBC AND QUANTIFIES MOLECULAR RESPONSE TO NADOFARAGENE FIRADENOVEC by Narayan, Vikram M., Tholomier, Come, Mokkapati, Sharada, Martini, Alberto, Caruso, Vincent M., Mazzarella, Brian C., Phillips, Kevin G., Bicocca, Vincent T., Levin, Trevor G., Sawutz, David, Yla-Herttuala, Seppo, Parker, Nigel, McConkey, David J., Dinney, Colin P. N.

Get full text

Urinary minimal residual disease detection predicts recurrence in BCG-unresponsive NIMBC and quantifies molecular response to nadofaragene firadenovec by Narayan, Vikram M, Tholomier, Come, Mokkapati, Sharada, Martini, Alberto, Caruso, Vincent M., Mazzarella, Brian C., Phillips, Kevin G., Bicocca, Vincent T., Levin, Trevor G., Yla-Herttuala, Seppo, Sawutz, David, Parker, Nigel, McConkey, David James, Dinney, Colin P.N.

“…635 Background: Urinary minimal residual disease (uMRD) profiling uses next-generation sequencing to identify mutations associated with urothelial carcinoma…”
Get full text

Correlation of urinary comprehensive genomic profile with risk of recurrence of BCG-unresponsive non-muscle invasive bladder cancer treated with atezolizumab in SWOG S1605 by St-Laurent, Marie-Pier, Plets, Melissa, Black, Peter C., Singh, Parminder, McConkey, David James, Lucia, Scott, Koshkin, Vadim S, Stratton, Kelly Lynn, Bivalacqua, Trinity, Kassouf, Wassim, Porten, Sima P., Bangs, Rick, Tangen, Catherine, Thompson, Ian M., Meeks, Joshua J, Caruso, Vincent M., Phillips, Kevin G., Bicocca, Vincent T., Levin, Trevor G., Lerner, Seth P.

“…529 Background: Radical cystectomy is recommended for patients with BCG-unresponsive (BU) non-muscle invasive bladder cancer (NMIBC) due to high risk of…”
Get full text